Showing results (151-160 of 357) with videos related to
Sort By:
Pageof 36
Cancer|July 19, 2002
Treating cancer with PEG Intron: pharmacokinetic profile and dosing guidelines for an improved interferon-alpha-2b formulationRonald M Bukowski, Craig Tendler, David Cutler, et al.Developmental Psychology|December 20, 2021
Contextual variations in associations between measures of aggression and withdrawal and functioning with peers: A replication studyWilliam M Bukowski, Melanie Dirks, Ryan Persram, et al.Cancer Research|January 15, 1994
Estrogen receptor mutations in tamoxifen-resistant breast cancerP S Karnik, S Kulkarni, X P Liu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Skeletal complications in patients with bone metastases from renal cell carcinoma and therapeutic benefits of zoledronic acidAllan Lipton, Alejandro Colombo-Berra, Ronald M Bukowski, et al.Journal of Developmental and Behavioral Pediatrics : JDBP|June 1, 1992
Social interactions between children with cancer or sickle cell disease and their peers: teacher ratingsR B Noll, M D Ris, W H Davies, et al.Investigational New Drugs|January 1, 1986
Phase I trial of intraperitoneal chemotherapy with 5-fluorouracil and citrovorum factorG T Budd, M J Schreiber, E Steiger, et al.Current Oncology Reports|February 14, 2003
New and modified interferon alfas: preclinical and clinical dataPaul Masci, Ronald M Bukowski, Phillip A Patten, et al.Investigational New Drugs|July 22, 2005
Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinomaPhilip E Shaheen, Walter Stadler, Paul Elson, et al.Clinical Genitourinary Cancer|July 25, 2006
Adjuvant subcutaneous interleukin-2 in patients with resected renal cell carcinoma: a pilot studyNavneet S Majhail, Laura Wood, Paul Elson, et al.Seminars in Oncology|May 29, 1999
Approaches to managing carboplatin-induced thrombocytopenia: focus on the role of amifostineG T Budd, R Ganapathi, L Wood, et al.Pageof 36